Dark

ILMN
Illumina Inc
stock NASDAQ

At Close

May 16, 2025 3:59:30 PM EDT

83.65USD+3.399%(+2.75)2,341,745

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 16, 2025 9:10:30 AM EDT

81.41USD+0.630%(+0.51)1,304

After-hours

May 16, 2025 4:50:30 PM EDT

83.63USD-0.024%(-0.02)19,376

OverviewOptionsHistoricalExchangesShortsNews

Jan 24, 2022

08:38AM EST Illumina collaborates With National Cancer Center Japan To Address A Leading Cause Of Death In Asia Benzinga

08:31AM EST Illumina collaborates with National Cancer Center Japan to address a leading PR Newswire

Jan 20, 2022

04:05PM EST Illumina to Announce Fourth Quarter & Full Year 2021 Financial Results on PR Newswire

Jan 18, 2022

07:29AM EST Stifel Upgrades Illumina to Buy Benzinga

Jan 12, 2022

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 12, 2022 Benzinga

06:39AM EST Barclays Upgrades Illumina to Equal-Weight, Raises Price Target to $400 Benzinga

Jan 11, 2022

01:07PM EST Analyst Ratings For Illumina Benzinga

10:58AM EST Shares of biotechnology company Illumina, Inc. (ILMN) are up 8 percent on Tuesday's trading after the company announced a multi-year agreement with Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center or VUMC to accelerate medicines development via large-scale genomics and the setting up of a pre-eminent clinico-genomic resource. RTTNews

10:27AM EST $100 Invested In This Stock 5 Years Ago, Would Be Worth This Much Benzinga

10:11AM EST Benzinga's Top Ratings Upgrades, Downgrades For January 11, 2022 Benzinga

09:23AM EST Barclays Upgrades Illumina to Equal-Weight Benzinga

08:36AM EST The Daily Biotech Pulse: Illumina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In Benzinga

07:32AM EST 10 Biggest Price Target Changes For Tuesday Benzinga

05:26AM EST A Peek Into The Markets: US Stock Futures Higher Ahead Of Powell Benzinga

04:39AM EST SVB Leerink Maintains Market Perform on Illumina, Raises Price Target to $430 Benzinga

Jan 10, 2022

04:30PM EST Illumina Collaborates With Nashville Biosciences To Accelerate Medicines Development Benzinga

04:29PM EST Illumina Reports Multi-Year Partnership With Agendia To Co Develop In Vitro Diagnostic Tests For Oncology Testing Benzinga

04:27PM EST Illumina Reports Companion Diagnostic Partnership With Boehringer Ingelheim, No Terms Disclosed Benzinga

04:27PM EST Illumina Sees Q4 Sales ~$1.19B vs $1.1B Estimate; FY22 Sales $5.15B-$5.24B vs $4.89B Estimate Benzinga

04:21PM EST Illumina collaborates with Nashville Biosciences to accelerate medicines PR Newswire

04:19PM EST Illumina Partners with Agendia to Expand Genomic Testing in Breast Cancer Care PR Newswire

04:19PM EST Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care Business Wire

04:17PM EST Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership PR Newswire

04:15PM EST deep pipeline of long-term growth opportunities at 2022 J.P. Morgan Healthcare Conference PR Newswire

09:02AM EST Barclays Maintains Underweight on Illumina, Lowers Price Target to $350 Benzinga

08:53AM EST Illumina's GRAIL Announces Knight Cancer Institute At Oregon Health & Science University To Offer Galleri Multi-Cancer Early Detection Test Benzinga

08:45AM EST Knight Cancer Institute at Oregon Health & Science University to Offer the Galleri(r) Multi-Cancer Early Detection Test Business Wire

08:15AM EST GRAIL and Premier's PINC AI(tm) Partner to Support Patient Access to Galleri(r) Multi-Cancer Early Detection Blood Test Business Wire

Jan 7, 2022

01:07PM EST Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022 Benzinga

01:04PM EST B of A Securities Upgrades Illumina to Neutral, Announces $390 Price Target Benzinga

Jan 6, 2022

10:02AM EST Price Over Earnings Overview: Illumina Benzinga

08:24AM EST The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales Benzinga

Jan 5, 2022

04:15PM EST Illumina Enters Co-Development Partnership with SomaLogic PR Newswire

04:15PM EST SomaLogic Announces Exclusive Partnership With Illumina To Develop Sequencing-based Proteomic Solutions; Companies To 'develop co-exclusive, co-branded, next-generation sequencing (NGS)-based proteomics products.' Benzinga

Jan 4, 2022

09:04AM EST Illumina Reports Partnership With Syapse On Research To Evaluate Large Panel Biomarker Testing Patterns Across US Community Oncology Practices Benzinga

09:00AM EST Syapse, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced a partnership with Illumina, Inc. (NASDAQ:ILMN),aimed at assessing the real-world uptake and actionability of comprehensive genomic profiling in the community oncology health system setting. GlobeNewswire Inc

Dec 23, 2021

04:05PM EST Illumina To Webcast Upcoming Investor Conference PR Newswire

Dec 20, 2021

07:05AM EST - Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296 million in gross proceeds, over $153 million of which is fully committed in a common stock Private Investment in Public Equity (PIPE) financing and from non-redemption agreements - GlobeNewswire Inc

Dec 14, 2021

03:21PM EST Gretel, Illumina Partner To Develop Synthetic Data For Genomic Research; Terms Not Disclosed Benzinga

Dec 9, 2021

09:44PM EST Illumina Supports Norway's Pioneering Precision Medicine Study to Assess the Efficacy of Blood-based Comprehensive Genomic Profiling in Cancer Therapy Selection Testing Benzinga

04:01AM EST Illumina Supports Norway's Pioneering Precision Medicine Study PR Newswire

Dec 6, 2021

07:21AM EST GRAIL Announces Partnership With Alignment Health Plan As First Medicare Advantage Plan To Offer Galleri Multi-Cancer Early Detection Blood Test Benzinga

07:10AM EST GRAIL Partners With Alignment Health As Medicare Advantage Plan To Offer Galleri Multi-Cancer Early Detection Blood Test RTTNews

07:05AM EST GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri(r) Multi-Cancer Early Detection Blood Test Business Wire

Nov 18, 2021

02:05PM EST Following Rough Year, Is Burning Rock Set To Turn The Corner? Benzinga

Nov 17, 2021

04:06PM EST Illumina and Sequoia Capital China Select First Startups to join Genomics PR Newswire

Nov 16, 2021

01:07PM EST Europe To Layout Objections to Illumina-Grail Deal: Bloomberg Benzinga

11:17AM EST Illumina, Genetic Alliance Launch $120M Global Initiative To Increase Equity, Improve Outcomes For Families Impacted By Genetic Disease Benzinga

11:16AM EST Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase PR Newswire

Nov 5, 2021

09:25AM EDT Illumina Sees FY21 Adj. EPS $5.50-$5.60 vs $5.73 Est. Benzinga

09:25AM EDT Illumina Q3 EPS $1.45 Beats $1.13 Estimate, Sales $1.11B Beat $1.04B Estimate Benzinga

Nov 4, 2021

04:26PM EDT Illumina Inc. (ILMN) on Thursday revised its financial guidance for the full year 2021. RTTNews

04:15PM EDT Illumina Q3 EPS $2.08 Vs. $1.21 Year Ago RTTNews

04:10PM EDT Illumina Inc. (ILMN) revealed earnings for its third quarter that increased from last year. RTTNews

04:06PM EDT Illumina Reports Financial Results for Third Quarter of Fiscal Year 2021 PR Newswire

08:19AM EDT The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO Benzinga

05:00AM EDT Earnings Scheduled For November 4, 2021 Benzinga

Nov 3, 2021

05:04PM EDT Illumina Reports Its Sequencing, Bioinfo Solutions Being Used By Part Of Canadian COVID-19 Genomics Network, No Terms Disclosed Benzinga

04:06PM EDT Illumina Supports Canada's Nationwide COVID-19 Genome Sequencing Initiative PR Newswire

Oct 31, 2021

02:24PM EDT The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline Benzinga

Oct 29, 2021

12:43PM EDT EC Adopts Interim Measure, Tells Grail To Work On Alternatives To Illumina Deal Benzinga

Oct 27, 2021

03:14AM EDT Illumina Agrees With Israel's MoH To Accelerate Diagnoses Of Critically-Ill Newborns With Suspected Genetic Disease RTTNews

03:05AM EDT Illumina Supports Israel's National Program to Accelerate Diagnoses of PR Newswire

Oct 20, 2021

06:00PM EDT Illumina to Host Inaugural ESG Investor Event on Tuesday, November 16, 2021 PR Newswire

Oct 19, 2021

04:55AM EDT SVB Leerink Maintains Market Perform on Illumina, Lowers Price Target to $420 Benzinga

Oct 14, 2021

07:42PM EDT Illumina Appoints Bob Ragusa As CEO Of GRAIL RTTNews

07:35PM EDT Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL PR Newswire

Oct 13, 2021

05:01PM EDT Illumina to Announce Third Quarter 2021 Financial Results on Thursday, November PR Newswire

Oct 1, 2021

10:17AM EDT OTR Global Downgrades Illumina to Mixed Benzinga

Sep 30, 2021

09:19AM EDT Illumina Opens Entities In Colombia And Mxico RTTNews

09:15AM EDT Illumina Expands Presence in Latin America PR Newswire

Sep 27, 2021

11:10AM EDT Illumina Says Randomized Trial Demonstrates Whole-Genome Sequencing Leads To Precision Care For Critically Ill Infants Benzinga

11:09AM EDT Randomized trial demonstrates whole-genome sequencing leads to precision care PR Newswire

Sep 20, 2021

02:30PM EDT Illumina Says Had Anticipated EU Antitrust Regulators Would Seek To Impose Hold Separate Order Regarding Grail Deal Benzinga

Sep 16, 2021

07:30AM EDT Dante Labs, a global leader in genomics and precision medicine, today announced the appointment of Rachel Haverfield to the companys leadership as General Counsel to drive the growth and scale of the business and opportunity. GlobeNewswire Inc

Sep 15, 2021

09:15AM EDT Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle PR Newswire

Sep 14, 2021

07:30AM EDT Dante Labs, a global leader in genomics and precision medicine, today announced the appointments of Andre Nel, Dalila Rahmani, Laura DAngelo and Omar Elbakshish to the companys management team, expanding its global leadership to help scale the growing business. GlobeNewswire Inc

Sep 13, 2021

02:57PM EDT UK's NHS Launches World's Largest Trial Of Blood Test For 50 Types Benzinga

Sep 9, 2021

09:31AM EDT Illumina Commits To Net Zero Global Greenhouse Gas Emissions By 2050 RTTNews

Sep 7, 2021

09:49AM EDT Illumina Inc. (ILMN) and Merck & Co Inc. (MRK) have partnered to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency or HRD, Illumina said in a statement. RTTNews

09:27AM EDT Illumina Partners With Merck To Develop And Commercialize Tests For Use In Identifying Specific Cancer Mutations RTTNews

09:21AM EDT Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer Mutations Benzinga

09:16AM EDT Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic PR Newswire

Aug 30, 2021

05:01PM EDT Illumina To Webcast Upcoming Investor Conference PR Newswire

Aug 24, 2021

10:31AM EDT Looking into Illumina's Return on Capital Employed Benzinga

Aug 23, 2021

09:00AM EDT To: All persons or entities who hold common stock ofIllumina, Inc. (Illumina or the Company) (NASDAQ: ILMN). GlobeNewswire Inc

Aug 20, 2021

07:45AM EDT European Commission To Assess Illumina's Possible Breach RTTNews

07:11AM EDT EU Starts Investigation For Possible Breach Of Standstill Obligation In Illumina/GRAIL Transaction RTTNews

Aug 19, 2021

10:57AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

10:10AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 19, 2021 Benzinga

07:37AM EDT The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck Benzinga

07:35AM EDT SVB Leerink Downgrades Illumina to Market Perform, Announces $425 Price Target Benzinga

Aug 18, 2021

04:40PM EDT Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test Benzinga

04:39PM EDT Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving PR Newswire

Aug 12, 2021

03:21PM EDT EU Regulators Temporarily Pause Illumina, Grail Deal Investigation Benzinga

Aug 6, 2021

08:17AM EDT Barclays Maintains Underweight on Illumina, Raises Price Target to $365 Benzinga

07:55AM EDT Illumina Q2 Earnings Boosted By Robust Growth In Core Sequencing Business; Uplifts FY21 Outlook Benzinga

Aug 5, 2021

06:09PM EDT Illumina: Q2 Earnings Insights Benzinga

04:39PM EDT Illumina Inc. (ILMN) revealed earnings for its second quarter that advanced from the same period last year. RTTNews

04:14PM EDT Illumina Reports Q2 EPS Of $1.26 Vs. $0.32 Last Year RTTNews

04:10PM EDT Illumina Sees FY21 Adj. EPS $6.30-$6.50 vs $6.02 Estimate Benzinga

04:09PM EDT Illumina Q2 Adj. EPS $1.87 Beats $1.35 Estimate, Sales $1.13B Beat $1.01B Estimate Benzinga

04:06PM EDT Illumina Reports Financial Results for Second Quarter of Fiscal Year 2021 PR Newswire

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 3, 2021

09:30PM EDT Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support PR Newswire

Jul 23, 2021

12:28PM EDT Illumina-Grail $8B Merger Hit By European Commission's In-Depth Investigation Benzinga

Jul 22, 2021

12:50PM EDT Illumina Affirms Commitment To Re-Acquire GRAIL Benzinga

12:49PM EDT Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase Business Wire

Jul 19, 2021

07:07AM EDT -- Bob Ragusa leads Illumina global operations and is a key contributor to Illumina's growth and global scaling. -- Dante Labs integrated precision medicine offering leverages the intersection of local lab operations with centralised software and database. -- Dante Labs mission is to accelerate science to patients to save more lives. GlobeNewswire Inc

Jul 14, 2021

11:51AM EDT Illumina, Grail Merger Faces Full-Scale European Probe Amid Antitrust Concerns: Reuters Benzinga

Jul 13, 2021

08:15AM EDT Barclays Maintains Underweight on Illumina, Raises Price Target to $355 Benzinga

Jun 1, 2021

11:09AM EDT Expert Ratings for Illumina Benzinga

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2021 Benzinga

07:17AM EDT Evercore ISI Group Upgrades Illumina to In-Line, Announces $400 Price Target Benzinga

03:11AM EDT Illumina Enters Deal With Belgian Genetic Centers On WGS For Diagnosis Of Patients With ID And/or DD In Routine Care RTTNews

03:05AM EDT Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis Business Wire

May 17, 2021

08:08AM EDT Illumina Appoints Susan Tousi As Chief Commercial Officer RTTNews

08:05AM EDT Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development Business Wire

May 3, 2021

04:05PM EDT Myriad Genetics Delivers 12% Sequential Revenue Growth in March GlobeNewswire Inc

Apr 29, 2021

09:58AM EDT Illumina Inc. (ILMN) said that it has filed an action in the General Court of the European Union asking for annulment of the European Commission's decision asserting jurisdiction to review Illumina's acquisition of GRAIL. RTTNews

09:18AM EDT Illumina Files Action For Annulment Of European Commission's Decision Asserting Jurisdiction To Review GRAIL Acquisition Benzinga

09:14AM EDT Illumina Files Action For Annulment Of EC's Decision Asserting Jurisdiction To Review GRAIL Acquisition RTTNews

09:05AM EDT Illumina Files Action for Annulment of European Commission's Decision Asserting Jurisdiction to Review GRAIL Acquisition Business Wire

Apr 28, 2021

10:48AM EDT Canaccord Genuity Maintains Buy on Illumina, Raises Price Target to $470 Benzinga

09:05AM EDT Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative Business Wire

08:30AM EDT Wells Fargo Maintains Underweight on Illumina, Raises Price Target to $340 Benzinga

Apr 27, 2021

05:25PM EDT Illumina Inc. (ILMN) revealed earnings for first quarter that dropped from last year. RTTNews

04:51PM EDT Illumina Q1 GAAP EPS $1.00 Vs $1.17 Last Year RTTNews

04:40PM EDT Illumina: Q1 Earnings Insights Benzinga

04:13PM EDT Illumina Sees FY21 EPS $5.80-$6.05 Vs. $5.51 Est. Benzinga

04:12PM EDT Illumina Q1 EPS $1.89 Beats $1.38 Estimate, Sales $1.09B Beat $995.85M Estimate Benzinga

07:41AM EDT The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout Benzinga

04:05AM EDT Earnings Scheduled For April 27, 2021 Benzinga

Apr 24, 2021

09:24AM EDT The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx Benzinga

Apr 23, 2021

07:56AM EDT Illumina, Kartos Therapeutics Team Up To Develop Companion Diagnostic For TP53-Haboring Cancer Indications Benzinga

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

Apr 22, 2021

04:11PM EDT Illumina, Kartos Therapeutics Announce New Oncology Partnership To Develop NGS-Based TP53 Companion Diagnostic RTTNews

04:08PM EDT Illumina Reports New Oncology Partnership With Kartos Therapeutics To Develop An Next-Gen Sequencing-Based Via TruSight Oncology 500 Benzinga

04:05PM EDT Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic Business Wire

Apr 20, 2021

08:45AM EDT Biotech Veterans Troy Cox, Susannah Gray and Karen McGinnis Join GlobeNewswire Inc

07:00AM EDT Llumina Remains Committed To GRAIL Deal - Quick Facts RTTNews

06:41AM EDT Illumina Says Disagrees With European Commission's Directorate-General For Competition's Decision To Review Co.'s Acquisition Of GRAIL Benzinga

06:40AM EDT Illumina Says Disagrees With European Commission's Directorate-General For Competition's Decision To Review GRAIL Deal RTTNews

06:30AM EDT Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test Business Wire

Apr 9, 2021

12:25PM EDT Ginkgo Bioworks, Which Prints DNA And Creates Genetically Modified Food, Exploring SPAC Deal: Report Benzinga

Apr 6, 2021

01:38PM EDT P/E Ratio Insights for Illumina Benzinga

10:33AM EDT Wells Fargo Maintains Underweight on Illumina, Raises Price Target to $330 Benzinga

09:11AM EDT Canaccord Genuity Maintains Buy on Illumina, Raises Price Target to $460 Benzinga

08:05AM EDT The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout Benzinga

06:28AM EDT A Peek Into The Markets: US Stock Futures Edge Lower Following Monday's Rally; Crude Oil Rises 2% Benzinga

Apr 5, 2021

04:31PM EDT Illumina Raises FY21 Sales Growth Guidance From ~17-20% Year Over Year To 25-28% YoY Benzinga

04:31PM EDT Illumina Sees Q1 Sales ~$1.085B vs $924.6M Estimate Benzinga

Mar 31, 2021

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2021 Benzinga

09:29AM EDT Looking Into Illumina's Return On Capital Employed Benzinga

08:07AM EDT Atlantic Equities Downgrades Illumina to Neutral, Announces $390 Price Target Benzinga

06:56AM EDT Canaccord Genuity Upgrades Illumina to Buy, Announces $445 Price Target Benzinga

06:12AM EDT Despite FTC Challenges Opposing Grail Acquisition, Illumina Committed To Pursue Deal: Report Benzinga

03:00AM EDT The U.S. Federal Trade Commission or FTC has challenged Illumina Inc.'s proposed $7.1 billion acquisition of cancer detection test maker Grail, alleging that a merger would harm competition for life-saving Multi-Cancer Early Detection or MCED tests in the United States. RTTNews

Mar 30, 2021

03:18PM EDT Illumina Issues Press Release Highlighting FTC Challenge Of Acquisition Of GRAIL, Says 'Disagrees, Opposes' Benzinga

03:17PM EDT Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test Business Wire

03:12PM EDT UPDATE: FTC To File Antitrust Suit Challenging Illumina's Deal For Grail, Alleges Deal Would Undermine Innovation For Early Detection Tests For Cancer Benzinga

02:58PM EDT Illumina Shares Tick Slightly Higher; FTC Has Challenged Co.'s Deal For Grail Benzinga

12:10PM EDT Ark Funds, Illumina Invest In SomaLogic SPAC Deal: What Investors Should Know Benzinga

Mar 28, 2021

11:39AM EDT From Smart Toothbrushes To Reimagined Tampons: RBC's 'Imagine 2025' Is Ahead Of Schedule Benzinga

Mar 20, 2021

11:11AM EDT What Scott Gottlieb Thinks About The Heated Exchange Between Anthony Fauci And Rand Paul Benzinga

Mar 19, 2021

04:00PM EDT What Dr. Scott Gottlieb Thinks About The Heated Exchange Between Dr. Anthony Fauci and U.S. Sen. Rand Paul Benzinga

Mar 18, 2021

04:05PM EDT Illumina Announces Board Changes Business Wire

Mar 16, 2021

10:02AM EDT Illumina Says Partners With Geneseeq To Develop, Commercialize Comprehensive Cancer In-Vitro Diagnostic NGS Kit In China Benzinga

07:30AM EDT Iridia Raises $24 Million in Series B Funding GlobeNewswire Inc

Mar 15, 2021

07:50AM EDT 'Fast Money' Picks For March 15 Benzinga

Mar 11, 2021

04:06PM EST Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women Business Wire

Mar 5, 2021

01:03AM EST Illumina, R-Pharm Secure Registration For Two Complete IVD Sequencing Platforms In Russia RTTNews

01:00AM EST Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia Business Wire

Mar 3, 2021

10:02AM EST Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2021 Benzinga

06:29AM EST Barclays Initiates Coverage On Illumina with Underweight Rating, Announces Price Target of $325 Benzinga

Mar 2, 2021

07:20AM EST Myriad Genetics Announces Collaboration With Intermountain Precision Genomics For Germline And Somatic Tumor Testing Services Using TheraMap Test And Sequencing Test From Illumina Benzinga

07:05AM EST Myriad Genetics Joins Forces with Intermountain Precision Genomics GlobeNewswire Inc

Feb 23, 2021

08:58AM EST US Court Grants MGI's Motion To Amend In Suit Against Illumina Benzinga

Feb 16, 2021

07:45AM EST 10 Biggest Price Target Changes For Tuesday Benzinga

07:40AM EST BTIG Maintains Buy on Illumina, Raises Price Target to $570 Benzinga

Feb 12, 2021

12:12PM EST Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $410 Benzinga

09:55AM EST Illumina shares were trading lower after the company issued FY21 EPS guidance below estimates. Benzinga

06:57AM EST SVB Leerink Maintains Outperform on Illumina, Raises Price Target to $470 Benzinga

Feb 11, 2021

04:30PM EST Illumina Q4 EPS $1.75 Vs. $1.61 Year Ago RTTNews

04:20PM EST Recap: Illumina Q4 Earnings Benzinga

04:11PM EST Illumina Sees FY21 Adj. EPS $5.10-$5.35 vs $6.11 Estimate, Sales Growth 17-20% Year Over Year Benzinga

04:10PM EST Illumina Q4 Adj. EPS $1.22 Beats $1.11 Estimate, Sales $953.00M Beat $903.92M Estimate Benzinga

03:51AM EST Earnings Scheduled For February 11, 2021 Benzinga

Feb 10, 2021

10:47AM EST A Preview Of Illumina's Earnings Benzinga

07:34AM EST The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs Benzinga

Feb 8, 2021

03:53PM EST Why Illumina's Stock Is Trading Higher Today Benzinga

09:07AM EST Illumina Reports Has Selected 9 New Genomics Companies To Join Second Global Funding Cycle Of Illumina Accelerator In US, UK Benzinga

09:05AM EST Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle Business Wire

Feb 6, 2021

12:42PM EST The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight Benzinga

Feb 4, 2021

05:00AM EST Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium Business Wire

Jan 31, 2021

07:47PM EST Illumina and Sequoia Capital China Announced Partnership to Launch Genomics Incubator in China Benzinga

07:40PM EST Illumina And Sequoia Capital China To Launch Genomics Incubator In China RTTNews

07:00PM EST Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China Business Wire

Jan 29, 2021

07:45AM EST The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO Benzinga

Jan 28, 2021

08:03AM EST The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO Benzinga

Jan 27, 2021

07:36AM EST The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement Benzinga

Jan 26, 2021

08:07AM EST The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga

Jan 20, 2021

04:08PM EST Illumina Wins Patent Infringement Suit Against BGI In UK RTTNews

04:05PM EST Illumina Wins Patent Infringement Suit Against BGI In The UK Benzinga

Jan 17, 2021

02:56PM EST 'Fast Money' Picks For January 19 Benzinga

Jan 11, 2021

02:10PM EST New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale Business Wire

02:08PM EST Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling Benzinga

02:06PM EST Myriad Genetics Forms Strategic Partnership with Illumina in Oncology For Illumina To Create A Kit-based Version Of The MyChoice Companion Diagnostic Test For International Markets Benzinga

02:05PM EST Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling Business Wire

02:05PM EST Note: Paul Diaz, President & CEO of Myriad Genetics will speak today at the 39th Annual JP Morgan Healthcare Conference at 2:50 p.m. EST accessible via a live audio webcast at the following direct link or through the investor section of Myriads website at www.myriad.com. GlobeNewswire Inc

Jan 6, 2021

07:31AM EST The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping Benzinga

05:48AM EST Illumina Announced Tuesday a Collaboration with Helix to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure Benzinga

Jan 5, 2021

08:31PM EST Illumina Inc. (ILMN) and Helix said that they have collaborated to assess prevalence of new SARS-CoV-2 UK variant (B.1.1.7) in the US and develop national surveillance infrastructure. RTTNews

07:48PM EST Illumina And Helix Collaborate To Assess Prevalence Of New SARS-CoV-2 UK Variant In US RTTNews

07:00PM EST Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure Business Wire

Dec 22, 2020

10:02AM EST Benzinga's Top Upgrades, Downgrades For December 22, 2020 Benzinga

08:22AM EST 10 Biggest Price Target Changes For Tuesday Benzinga

06:17AM EST Piper Sandler Upgrades Illumina to Overweight, Raises Price Target to $415 Benzinga

Dec 17, 2020

10:17AM EST Benzinga's Top Upgrades, Downgrades For December 17, 2020 Benzinga

08:54AM EST BTIG Upgrades Illumina to Buy, Announces $410 Price Target Benzinga

Dec 16, 2020

08:10AM EST Emedgene Reports Non-Exclusive Partnership With Illumina To Integrate, Automate Interpretation Into Illumina's TruSight Software Suite Benzinga

Dec 8, 2020

04:11PM EST Illumina Reports Risk-Sharing Deal With Harvard Pilgrim Health Care 'to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021' Benzinga

04:05PM EST Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing Business Wire

Dec 7, 2020

08:06AM EST 10 Biggest Price Target Changes For Monday Benzinga

06:59AM EST SVB Leerink Maintains Outperform on Illumina, Raises Price Target to $360 Benzinga

Nov 17, 2020

08:03AM EST Leading Diagnostics Companies Join Forces to Establish the Access to PR Newswire

Nov 12, 2020

04:10PM EST Illumina Announces Commercial Availability Of The P3 High-output Flow Cell RTTNews

04:05PM EST Realize the Full Potential of the NextSeq 2000 with the Power of the P3 Reagent Kit Business Wire

03:16PM EST Twist Bioscience Reports Co., Illumina, Western Digital Form Alliance With Microsoft 'to advance the field of DNA data storage' Benzinga

Oct 30, 2020

05:16AM EDT SVB Leerink Maintains Outperform on Illumina, Raises Price Target to $325 Benzinga

Oct 29, 2020

05:31PM EDT Illumina Q3 EPS $1.21 Vs. $1.58 Year Ago RTTNews

05:12PM EDT Illumina: Q3 Earnings Insights Benzinga

04:27PM EDT Illumina Q3 EPS $1.02 Beats $0.77 Estimate, Sales $794.00M Beat $715.91M Estimate Benzinga

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

04:08AM EDT Earnings Scheduled For October 29, 2020 Benzinga

Oct 15, 2020

08:23AM EDT IDbyDNA, Illumina Launch New Rapid Test To Better Detect Respiratory Co-Infections, Identify Antibiotic Resistant Pathogens Benzinga

Oct 13, 2020

09:38AM EDT Benzinga's Top Upgrades, Downgrades For October 13, 2020 Benzinga

08:25AM EDT Guggenheim Downgrades Illumina to Neutral Benzinga

Sep 30, 2020

09:35AM EDT Benzinga's Top Upgrades, Downgrades For September 30, 2020 Benzinga

07:26AM EDT Atlantic Equities Initiates Coverage On Illumina with Overweight Rating, Announces Price Target of $355 Benzinga

Sep 28, 2020

07:12AM EDT Cramer Shares His Thoughts On Boeing, General Electric And More Benzinga

Sep 22, 2020

02:27PM EDT Illumina Analysts Question Grail Deal's Commercial Opportunity, Hefty Price Tag Benzinga

10:03AM EDT Canaccord Genuity Maintains Hold on Illumina, Lowers Price Target to $300 Benzinga

09:57AM EDT Looking Into Illumina's Return On Capital Employed Benzinga

09:36AM EDT Benzinga's Top Upgrades, Downgrades For September 22, 2020 Benzinga

08:16AM EDT 10 Biggest Price Target Changes For Tuesday Benzinga

08:14AM EDT Baird Maintains Neutral on Illumina, Lowers Price Target to $281 Benzinga

07:09AM EDT UBS Downgrades Illumina to Neutral, Lowers Price Target to $285 Benzinga

06:47AM EDT Stifel Downgrades Illumina to Hold, Lowers Price Target to $280 Benzinga

06:12AM EDT SVB Leerink Maintains Outperform on Illumina, Lowers Price Target to $315 Benzinga

document.getElementById("vrMCNN").onerror = function(){this.style.display='none';}; .dark-mode .n6YKcW{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .n6YKcW{ color: #333333; background-color: white; border: 2px solid #333333; }ILMNIllumina Incstock NASDAQ

ILMN
Illumina Inc
stock NASDAQ